KO
Kathryn O'Reilly
Dermatology Residency · New York Presbyterian Hospital
Credentials: · · ·
History
2026–Present- 2018–2022
University of Delaw
2004–2008
Research
mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt
Cancer Research · 2006 · First of 12 authors · 2,177 citations
Cancer Cell · 2005 · 361 citations
Phosphorylated 4E-BP1 is associated with poor survival in melanoma
Clinical Cancer Research · 2009 · First of 12 authors · 55 citations
- NR
4 papers
3 papers
3 papers
- AF
2 papers
2 papers
- BM
2 papers
2 papers
- HK
2 papers
